Back to Russell Investments Group, Ltd. Russell Investments Group, Ltd.

CPRXCPRX
27 quarters

Position history for Russell Investments Group, Ltd.Russell Investments Group, Ltd.'s holdings in CATALYST PHARMACEUTICALS INC

Russell Investments Group, Ltd. holds 108,287 shares of CPRX (CATALYST PHARMACEUTICALS INC), worth $3.4M as of 2026-Q2. The position was increased (+0.8% shares). CPRX represents 0.0% of Russell Investments Group, Ltd.'s portfolio.

Current Value

$3.4M

Current Shares

108,287

Total Value Change

+$2.5M

Total Shares Change

-131,369

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
108,287
+0.8%
$3.4M0.0%$31.43
27
2026-Q1
Decreased
107,372
-11.6%
$2.7M0.0%$23.92
0
2025-Q4
Decreased
121,411
-7.4%
$2.8M0.0%$23.29
0
2025-Q3
Decreased
131,056
-23.5%
$2.6M0.0%$19.55
0
2025-Q2
Increased
171,395
+20.9%
$3.7M0.0%$21.78
32
2025-Q1
Decreased
141,753
-19.6%
$3.4M0.0%$24.69
0
2024-Q4
Increased
176,259
+1.4%
$3.7M0.0%$21.07
27
2024-Q3
Decreased
173,788
-19.4%
$3.5M0.0%$19.56
0
2024-Q2
Decreased
215,537
-9.3%
$3.3M0.0%$15.49
0
2024-Q1
Increased
237,744
+23.9%
$3.8M0.0%$15.94
32
2023-Q4
Increased
191,881
+5.5%
$3.2M0.0%$16.81
28
2023-Q3
Decreased
181,868
-7.4%
$2.1M0.0%$11.69
0
2023-Q2
Decreased
196,390
-45.8%
$2.6M0.0%$13.53
0
2023-Q1
Increased
362,517
+31.2%
$6M0.0%$16.46
34
2022-Q4
Decreased
276,286
-6.5%
$5.1M0.0%$18.60
0
2022-Q3
Decreased
295,620
-32.6%
$3.8M0.0%$12.70
0
2022-Q2
Increased
438,681
+8.7%
$3.1M0.0%$6.95
29
2022-Q1
Decreased
403,615
-13.8%
$3.3M0.0%$8.28
0
2021-Q4
Increased
468,222
+4.3%
$3.2M0.0%$6.89
28
2021-Q3
Decreased
449,136
-7.2%
$2.4M0.0%$5.02
0
2021-Q2
Decreased
484,139
-26.7%
$2.8M0.0%$5.78
0
2021-Q1
Increased
660,175
+48.1%
$3M0.0%$4.34
36
2020-Q4
Increased
445,720
+9.3%
$1.5M0.0%$3.42
28
2020-Q3
Increased
407,643
+30.2%
$1.2M0.0%$3.21
32
2020-Q2
Decreased
313,057
-2.2%
$1.4M0.0%$4.56
0
2020-Q1
Increased
319,985
+33.5%
$1.2M0.0%$3.88
33
2019-Q4
New
239,656
-
$896,0000.0%$3.67
34

Other major holders of CPRX: BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used